PCM
IOVA icon

Peregrine Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Peregrine Capital Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-301,068
Closed -$1.84M – 326
2023
Q1 		$1.84M Buy
301,068
+8,903
+3% +$61.4K 0.05% 246
2022
Q4 		$1.87M Buy
292,165
+50,671
+21% +$396K 0.06% 242
2022
Q3 		$2.31M Sell
241,494
-13,318
-5% -$154K 0.07% 244
2022
Q2 		$2.81M Sell
254,812
-2,964
-1% -$38.8K 0.08% 248
2022
Q1 		$4.29M Buy
257,776
+5,926
+2% +$91.6K 0.1% 249
2021
Q4 		$4.81M Buy
251,850
+46,016
+22% +$1.01M 0.1% 248
2021
Q3 		$5.08M Sell
205,834
-40,748
-17% -$960K 0.11% 247
2021
Q2 		$6.42M Buy
246,582
+10,398
+4% +$270K 0.12% 255
2021
Q1 		$7.48M Sell
236,184
-33,045
-12% -$1.37M 0.14% 250
2020
Q4 		$12.5M Sell
269,229
-101,839
-27% -$4.04M 0.24% 204
2020
Q3 		$12.2M Sell
371,068
-35,333
-9% -$1.08M 0.32% 115
2020
Q2 		$11.2M Buy
406,401
+26,983
+7% +$887K 0.32% 121
2020
Q1 		$11.4M Sell
379,418
-162,558
-30% -$4.31M 0.41% 105
2019
Q4 		$15M Sell
541,976
-101,439
-16% -$2.31M 0.38% 116
2019
Q3 		$11.7M Sell
643,415
-14,236
-2% -$315K 0.32% 127
2019
Q2 		$16.1M Sell
657,651
-173,864
-21% -$2.62M 0.4% 109
2019
Q1 		$7.91M Buy
+831,515
New +$8.08M 0.2% 203

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Peregrine Capital Management's IOVA Position: Q2 2023 in Review

Peregrine Capital Management sold out of Iovance Biotherapeutics (IOVA) in Q2 2023, closing a stake of 301,068 shares — an estimated $1.84M sold.

Peregrine Capital Management first reported a position in IOVA in Q1 2019 and held it in 17 quarters. The position peaked at $16.1M in Q2 2019. 219 funds tracked by Wall St. Rank hold IOVA as of Q2 2023.

  • Peregrine Capital Management reported no remaining Iovance Biotherapeutics position as of Q2 2023 after selling out during the quarter.
  • Peregrine Capital Management sold 301,068 Iovance Biotherapeutics shares in Q2 2023, an estimated $1.84M.
  • Peregrine Capital Management first reported a position in Iovance Biotherapeutics in Q1 2019 and held it in 17 quarters.
  • Peregrine Capital Management's Iovance Biotherapeutics position peaked at $16.1M in Q2 2019.
  • 219 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2023.

Based on Peregrine Capital Management's 13F filing for Q2 2023, filed 26 Jul 2023.